Third Harmonic Bio, Inc. (THRD)
NASDAQ: THRD · IEX Real-Time Price · USD
11.81
-0.20 (-1.67%)
At close: Jul 19, 2024, 4:00 PM
11.82
+0.01 (0.08%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Third Harmonic Bio Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Third Harmonic Bio stock have an average target of 16, with a low estimate of 7.00 and a high estimate of 23. The average target predicts an increase of 35.48% from the current stock price of 11.81.
Analyst Consensus: Buy
* Price targets were last updated on Jun 18, 2024.
Analyst Ratings
The average analyst rating for THRD stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +94.75% | Jun 18, 2024 |
| Raymond James | Raymond James | Buy Initiates $18 | Buy | Initiates | $18 | +52.41% | Jun 7, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $5 → $7 | Hold | Maintains | $5 → $7 | -40.73% | Aug 11, 2023 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $34 → $5 | Buy → Hold | Downgrades | $34 → $5 | -57.66% | Dec 16, 2022 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $30 → $3.6 | Strong Buy → Hold | Downgrades | $30 → $3.6 | -69.52% | Dec 16, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.16
from -0.78
EPS Next Year
-1.60
from -1.16
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a | n/a | n/a |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.00 | -1.25 | -1.53 | -1.64 | -1.64 |
| Avg | -1.16 | -1.60 | -2.06 | -1.59 | -1.59 |
| Low | -1.28 | -1.87 | -2.26 | -1.53 | -1.53 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.